Epigenetics in Kidney Transplantation

作者: Valeria R. Mas , Thu H. Le , Daniel G. Maluf

DOI: 10.1097/TP.0000000000000878

关键词: ImmunologyChromatin remodelingBioinformaticsRegulation of gene expressionDNA methylationKidney transplantationKidney metabolismEpigeneticsmicroRNAEpigenomeBiologyTransplantation

摘要: Epigenetic modifications are changes to the genome that occur without any alteration in DNA sequence. These include cytosine methylation of at cytosine-phosphate diester-guanine dinucleotides, histone modifications, microRNA interactions, and chromatin remodeling complexes. may exert their effect independently or complementary genetic variants have potential modify gene expression. dynamic, potentially heritable, can be induced by environmental stimuli drugs. There is emerging evidence epigenetics play an important role health disease. However, impact epigenetic on outcomes kidney transplantation currently poorly understood deserves further exploration. Kidney best treatment option for end-stage renal disease, but allograft loss remains a significant challenge leads increased morbidity return dialysis. influence activation, proliferation, differentiation immune cells, therefore critical host response its outcome. The epigenome donor also graft survival, especially those associated with early transplant stressors (e.g., cold ischemia time) aging. In present review, we discuss supporting ischemia-reperfusion injury, graft, injury as new tools diagnosis prediction function, therapeutic targets improving transplantation.

参考文章(211)
Josef Zadrazil, Sadek Al-Jabry, Karel Krejeí, Petr Bachleda, Protocol biopsy of donor kidney in renal transplantation. Annals of Transplantation. ,vol. 9, pp. 8- 11 ,(2004)
Valeria R. Mas, Mariano J. Scian, Kellie J. Archer, Jihee L. Suh, Krystle G. David, Qing Ren, Todd W. B. Gehr, Anne L. King, Marc P. Posner, Thomas F. Mueller, Daniel G. Maluf, Pretransplant transcriptome profiles identify among kidneys with delayed graft function those with poorer quality and outcome. Molecular Medicine. ,vol. 17, pp. 1311- 1322 ,(2011) , 10.2119/MOLMED.2011.00159
Bala Gür Dedeoğlu, High-Throughput Approaches for MicroRNA Expression Analysis miRNomics: MicroRNA Biology and Computational Analysis. ,vol. 1107, pp. 91- 103 ,(2014) , 10.1007/978-1-62703-748-8_6
Aimee L. Jackson, Arthur A. Levin, Developing microRNA Therapeutics: Approaching the Unique Complexities Nucleic Acid Therapeutics. ,vol. 22, pp. 213- 225 ,(2012) , 10.1089/NAT.2012.0356
Mitsuo Kato, Rama Natarajan, Diabetic nephropathy—emerging epigenetic mechanisms Nature Reviews Nephrology. ,vol. 10, pp. 517- 530 ,(2014) , 10.1038/NRNEPH.2014.116
P. G. Dean, W. D. Park, L. D. Cornell, J. M. Gloor, M. D. Stegall, Intragraft Gene Expression in Positive Crossmatch Kidney Allografts: Ongoing Inflammation Mediates Chronic Antibody-Mediated Injury American Journal of Transplantation. ,vol. 12, pp. 1551- 1563 ,(2012) , 10.1111/J.1600-6143.2011.03964.X
Elisabeth M Zeisberg, Michael Zeisberg, The role of promoter hypermethylation in fibroblast activation and fibrogenesis The Journal of Pathology. ,vol. 229, pp. 264- 273 ,(2013) , 10.1002/PATH.4120
Fumiaki Sato, Soken Tsuchiya, Stephen J. Meltzer, Kazuharu Shimizu, MicroRNAs and epigenetics. FEBS Journal. ,vol. 278, pp. 1598- 1609 ,(2011) , 10.1111/J.1742-4658.2011.08089.X
Damodar Kumbala, Rubin Zhang, Essential concept of transplant immunology for clinical practice. World journal of transplantation. ,vol. 3, pp. 113- 118 ,(2013) , 10.5500/WJT.V3.I4.113
S. A. Lodhi, K. E. Lamb, H. U. Meier-Kriesche, Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. American Journal of Transplantation. ,vol. 11, pp. 1226- 1235 ,(2011) , 10.1111/J.1600-6143.2011.03539.X